STOCK TITAN

Henry Schein to Webcast Third Quarter 2024 Conference Call on Tuesday, November 5, 2024 at 10:00 a.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags
conferences earnings

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its plans to release third quarter 2024 financial results. The company will unveil these results before the stock market opens on Tuesday, November 5, 2024.

Following the release, Henry Schein will host a live webcast of its earnings conference call at 10:00 a.m. Eastern time on the same day. The call will feature key speakers including Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, and Ronald N. South, Senior Vice President and Chief Financial Officer.

Investors can access the webcast at https://investor.henryschein.com/webcasts. A replay of the presentation will be made available on the Henry Schein website after the event.

Henry Schein, Inc. (Nasdaq: HSIC), il più grande fornitore mondiale di soluzioni per la salute destinato a professionisti dentali e medici che lavorano in ufficio, ha annunciato i suoi piani per rilasciare i risultati finanziari del terzo trimestre del 2024. L'azienda svelerà questi risultati prima dell'apertura del mercato azionario martedì 5 novembre 2024.

Subito dopo il rilascio, Henry Schein ospiterà un webcast in diretta della sua conferenza sui risultati alle 10:00 ora orientale nello stesso giorno. La chiamata presenterà relatori principali tra cui Stanley M. Bergman, Presidente del Consiglio e Amministratore Delegato, e Ronald N. South, Vice Presidente Senior e Direttore Finanziario.

Gli investitori possono accedere al webcast su https://investor.henryschein.com/webcasts. Una registrazione della presentazione sarà disponibile sul sito web di Henry Schein dopo l'evento.

Henry Schein, Inc. (Nasdaq: HSIC), el proveedor más grande del mundo de soluciones de atención médica para profesionales dentales y médicos en oficinas, ha anunciado sus planes para publicar los resultados financieros del tercer trimestre de 2024. La compañía revelará estos resultados antes de que abra el mercado de valores el martes 5 de noviembre de 2024.

Tras la publicación, Henry Schein organizará un webcast en vivo de su conferencia de ganancias a las 10:00 a.m. hora del este el mismo día. La llamada contará con oradores principales, incluyendo a Stanley M. Bergman, Presidente del Consejo y Director Ejecutivo, y Ronald N. South, Vicepresidente Senior y Director Financiero.

Los inversores pueden acceder al webcast en https://investor.henryschein.com/webcasts. Una repetición de la presentación estará disponible en el sitio web de Henry Schein después del evento.

헨리 샤인(주) (Nasdaq: HSIC), 사무실 기반의 치과 및 의료 전문인에게 건강 관리 솔루션을 제공하는 세계 최대 제공업체,는 2024년 3분기 재무 결과 발표 계획을 발표했습니다. 이 회사는 2024년 11월 5일 화요일 주식 시장 개장 전에 이 결과를 공개할 예정입니다.

발표 후, 헨리 샤인은 동부 표준시 오전 10시에 실시간 수익 전화 회의를 개최합니다. 이 전화 회의에는 스탠리 M. 버그만, 이사회 의장 겸 CEO, 로나드 N. 사우스, 수석 부사장 겸 CFO와 같은 주요 연사가 참석할 것입니다.

투자자는 https://investor.henryschein.com/webcasts에서 웹캐스트에 접속할 수 있습니다. 행사 후, 헨리 샤인 웹사이트에서 프레젠테이션 녹화본이 제공될 예정입니다.

Henry Schein, Inc. (Nasdaq: HSIC), le plus grand fournisseur mondial de solutions de santé pour les praticiens dentaires et médicaux de bureau, a annoncé ses projets de publication des résultats financiers du troisième trimestre 2024. L'entreprise dévoilera ces résultats avant l'ouverture du marché boursier le mardi 5 novembre 2024.

Après la publication, Henry Schein organisera un webinaire en direct de sa conférence sur les résultats à 10h00, heure de l'Est le même jour. L'appel comportera des intervenants clés, notamment Stanley M. Bergman, Président du Conseil d'Administration et Directeur Général, et Ronald N. South, Vice-Président Sénior et Directeur Financier.

Les investisseurs peuvent accéder au webinaire à https://investor.henryschein.com/webcasts. Un enregistrement de la présentation sera disponible sur le site web de Henry Schein après l'événement.

Henry Schein, Inc. (Nasdaq: HSIC), der weltweit größte Anbieter von Gesundheitslösungen für zahnmedizinische und medizinische Fachkräfte in Praxen, hat seine Pläne zur Veröffentlichung der finanziellen Ergebnisse des dritten Quartals 2024 bekannt gegeben. Das Unternehmen wird diese Ergebnisse vor der Eröffnung der Börse am Dienstag, den 5. November 2024 vorstellen.

Nach der Veröffentlichung wird Henry Schein einen Live-Webcast seiner Ergebnis-Konferenz um 10:00 Uhr Eastern Time am selben Tag veranstalten. An dem Anruf werden wichtige Sprecher teilnehmen, darunter Stanley M. Bergman, Vorsitzender des Vorstands und CEO, sowie Ronald N. South, Senior Vice President und CFO.

Investoren können auf den Webcast unter https://investor.henryschein.com/webcasts zugreifen. Eine Wiederholung der Präsentation wird nach der Veranstaltung auf der Website von Henry Schein verfügbar sein.

Positive
  • None.
Negative
  • None.

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2024 financial results before the stock market opens on Tuesday, November 5, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time.

Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer.

Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the presentation.

Cautionary Note Regarding Forward-Looking Statements

In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements include EPS and Adjusted EBITDA guidance and are generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms. A fuller discussion of our operations, financial condition and status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission, or SEC, including our Annual Report on Form 10-K, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: our dependence on third parties for the manufacture and supply of our products; our ability to develop or acquire and maintain and protect new products (particularly technology products) and technologies that achieve market acceptance with acceptable margins; transitional challenges associated with acquisitions, dispositions and joint ventures, including the failure to achieve anticipated synergies/benefits, as well as significant demands on our operations, information systems, legal, regulatory, compliance, , financial and human resources functions in connection with acquisitions, dispositions and joint ventures; certain provisions in our governing documents that may discourage third-party acquisitions of us; adverse changes in supplier rebates or other purchasing incentives; risks related to the sale of corporate brand products; security risks associated with our information systems and technology products and services, such as cyberattacks or other privacy or data security breaches (including the October 2023 incident); effects of a highly competitive (including, without limitation, competition from third-party online commerce sites) and consolidating market; changes in the health care industry; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global and domestic macro-economic and political conditions, including inflation, deflation, recession, ongoing wars, fluctuations in energy pricing and the value of the U.S. dollar as compared to foreign currencies, and changes to other economic indicators, international trade agreements, potential trade barriers and terrorism; geopolitical wars; failure to comply with existing and future regulatory requirements; risks associated with the EU Medical Device Regulation; failure to comply with laws and regulations relating to health care fraud or other laws and regulations; failure to comply with laws and regulations relating to the collection, storage and processing of sensitive personal information or standards in electronic health records or transmissions; changes in tax legislation; risks related to product liability, intellectual property and other claims; risks associated with customs policies or legislative import restrictions; risks associated with disease outbreaks, epidemics, pandemics (such as the COVID-19 pandemic), or similar wide-spread public health concerns and other natural or man-made disasters; risks associated with our global operations; litigation risks; new or unanticipated litigation developments and the status of litigation matters; our dependence on our senior management, employee hiring and retention, and our relationships with customers, suppliers and manufacturers; and disruptions in financial markets. The order in which these factors appear should not be construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements except as required by law.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our main distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

Investors

Ronald N. South

Senior Vice President and Chief Financial Officer

ronald.south@henryschein.com

(631) 843-5500

Graham Stanley

Vice President, Investor Relations and Strategic Finance Project Officer

graham.stanley@henryschein.com

(631) 843-5500

Media

Ann Marie Gothard

Vice President, Global Corporate Media Relations

annmarie.gothard@henryschein.com

(631) 390-8169

Source: Henry Schein, Inc.

FAQ

When will Henry Schein (HSIC) release its Q3 2024 financial results?

Henry Schein (HSIC) will release its third quarter 2024 financial results before the stock market opens on Tuesday, November 5, 2024.

What time is Henry Schein's (HSIC) Q3 2024 earnings conference call?

Henry Schein's (HSIC) Q3 2024 earnings conference call is scheduled for Tuesday, November 5, 2024, at 10:00 a.m. Eastern time.

Who will be speaking at Henry Schein's (HSIC) Q3 2024 earnings call?

Speakers on Henry Schein's (HSIC) Q3 2024 earnings call will include Stanley M. Bergman, Chairman of the Board and CEO, and Ronald N. South, Senior VP and CFO.

How can investors access Henry Schein's (HSIC) Q3 2024 earnings webcast?

Investors can access Henry Schein's (HSIC) Q3 2024 earnings webcast by visiting https://investor.henryschein.com/webcasts.

Henry Schein Inc

NASDAQ:HSIC

HSIC Rankings

HSIC Latest News

HSIC Stock Data

8.78B
123.38M
0.9%
107.47%
5.18%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States of America
MELVILLE